Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to the use of these compounds in treating brain cancer.
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
[EN] COMPOUNDS AND THERAPEUTICAL USE THEREOF<br/>[FR] COMPOSES ET UTILISATION THERAPEUTIQUE ASSOCIEE
申请人:MYRIAD GENETICS INC
公开号:WO2006074147A2
公开(公告)日:2006-07-13
[EN] Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs. [FR] L'invention concerne des 4-arylamino-quinazolines et des analogues de celles-ci, efficaces en tant qu'activateurs de caspases et inducteurs d'apoptose. Les composés selon l'invention sont utiles dans le traitement de divers états cliniques caractérisés par une croissance et une propagation incontrôlées de cellules anormales.